Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-α)-stimulated adipocytes

Journal of Cellular Biochemistry

Volumn 106, Issue 2, 2009, Pages 257-266

  Si, Young Cho ^a   Pil, Joon Park ^a   Eui, Seok Shin ^a   Jung, Ho Lee ^a   Hui, Kyoung Chang ^a   Tae, Ryong Lee ^a  

^a AmorePacific Corporation   (South Korea)

Author keywords

Adipocyte; Lipolysis; Mitochondria; Proteomics

Indexed keywords

CYTOKINE; ISOPRENALINE; MITOCHONDRIAL PROTEIN; PROHIBITIN; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE TRIPHOSPHATE; FATTY ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; ENERGY YIELD; FATTY ACID OXIDATION; INFLAMMATION; LIPOLYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; ANIMAL; CELL LINE; DRUG EFFECT; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; PROTEIN FOLDING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOSINE TRIPHOSPHATE; ADIPOCYTES; ANIMALS; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY ACIDS; ISOPROTERENOL; LIPID METABOLISM; MICE; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN FOLDING; PROTEOMICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61449199440     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21998     Document Type: Article

References (32)

1. Bogacka I, Xie H, Bray GA, Smith SR. 2005. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54:1392-1399.
2. Bruce CR, Carey AL, Hawley JA, Febbraio MA. 2003. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes. Diabetes 52:2338-2345.
3. Fasshauer M, Kein J, Neumann S, Eszlinger M, Paschke R. 2001. Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507:142-146.
4. Fridlyand LE, Philipson LH. 2006. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Obes Metab 8:136-145.
5. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y. 2007. beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes. Eur J Pharmacol 569:155-162.
6. Garcia-Vicente S, Abella A, Viguerie N, Ros-Baro A, Camps M, Testar X, Palacin M, Zorzano A, Marti L. 2005. The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha. J Physiol Biochem 61:395-401.
7. Green A, Rumgerger JM, Stuart CA, Ruhoff MS. 2004. Stimulation of lipolysis by tumor necrosis factor-α in 3T3-L1 adipocytes is glucose dependent. Diabetes 53:74-81.
8. Hoffmann R, Baillie GS, MacKenzie SJ, Yarwood SJ, Houslay MD. 1999. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J 18:893-903.
9. Jo SH, Son MK, Koh HJ, Lee SM, Song IH, Kim YO, Lee YS, Jeong KS, Kim WB, Park JW, Song BJ, Huh TL. 2001. Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem 276:16168-16176.
10. Kakuda TN. 2000. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22:685-708.
11. Klopstock T, Naumann M, Seibe P, Shalke B, Reingers K, Reichmann H. 1997. Mitochondrial DNA mutations in multiple symmetric lipomatosis. Mol Cell Biochem 174:271-275.
12. Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, Rondinone CM. 1999. On the control of lipolysis in adipocytes. Sciences 892:155-168.
13. Merkwirth C, Langer T. 2008. Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 17: (in press).
14. Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. 2004. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 53:2610-2616.
15. Munoz-Malaga A, Bautista J, Salazar JA, Aguilera I, Garcia R, Chinchon I, Segura MD, Campos Y, Arenas J. 2000. Lipomatosis, proximal myopathy, and the mitochondrial 8344 mutation. A. lipid storage myopathy? Muscle Nerve 23:538-542.
16. Nijtmans LG, Artal SM, Grivell LA, Coates PJ. 2002. The mitochondrial PHB complex: Roles in mitochondrial respiratory complex assembly, against and degenerative disease. Cell Mol Life Sci 59:143-155.
17. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671.
18. Rhee SG, Chae HZ, Kim K. 2005. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38:1543-1552.
19. Schleicher M, Shepherd BR, Suarez Y, Femandez-Hemando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC. 2008. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 180:101-112.
20. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. 1992. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267:5317-5323.
21. Seaver LC, Imlay JA. 2001. Hydrogen peroxide fluxes and compartmentalization inside growing Escherichia coli. J Bacteriol 183:7182-7189.
22. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS. 1998. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor α to increase lipolysis in 3T3-L1 adiopocytes. J Biol Chem 273:24665-24669.
23. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104:531-543.
24. Szabo C, Hasko G, Zingarelli B, Nemeth ZH, Salzman AL, Kvetan V, Pastores SM, Vizi ES, Balaban RS. 1997. Isoproterenol regulates tumor necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90:95-100.
25. Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M. 2006. Dual beta-adrenergic modulation in the immune system: Stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem Int 49:94-103.
26. Tatsumi T, Matoba S, Kawahara A, Keira N, Shiraishi J, Akashi K, Kobara M, Tanaka T, Katamura M, Nakagawa C, Ohta B, Shirayama T, Takeda K, Asayama J, Fliss H, Nakagawa M. 2000. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J Am Coll Cardiol 35:1338-1346.
27. Theiss AL, Idell RD, Srinivasan S, Klapproth JM, Jones DP, Merlin D, Sitaraman SV. 2007. Prohibitin protects against oxidative stress in interstinal epithelial cells. FASEB J 21:197-206.
28. Unlü M, Morgan ME, Minden JS. 1997. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 18:2071-2077.
29. Watabe S, Hiroi T, Yamamoto Y, Fujioka Y, Hasegawa H, Yago N, Takahashi SY. 1997. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 249:52-60.
30. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S, Czech M, Corvera S. 2003. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23:1085-1094.
31. Wlodek D, Gonzales M. 2003. Decrease energy levels can cause and sustain obesity. J Theor Biol 225:33-44.
32. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. 2002. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935.